Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Lia DeGroot
ldegroot@endpointsnews.com
author articles
Why the Supreme Court's overrule of Chevron has major implications for the FDA
Last year
Pharma
FDA+
House panel advances bill to allow Medicare to cover obesity drugs
Last year
Pharma
FDA+
Haleon to sell nicotine replacement therapy business to Dr. Reddy’s for $630M
Last year
Deals
Pharma
Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity
Last year
Pharma
FDA+
CBER chief floats rare disease hub to better communicate across centers
Last year
Pharma
FDA+
International society criticizes Utah law for permitting unapproved stem cell therapies
Last year
Pharma
Cell/Gene Tx
Amgen nabs new Blincyto approval for certain type of leukemia
Last year
Pharma
FDA+
FDA asks Covid-19 vaccine makers to instead target KP.2 strain for fall season
Last year
Pharma
FDA+
Stakeholders weigh in on potential reforms to FDA advisory committee process
Last year
Pharma
FDA+
Lilly, Eisai and Biogen seek more specifics in FDA guidance on early Alzheimer’s disease
Last year
Pharma
FDA+
Updated: FDA funding would stay flat under House appropriations bill
Last year
Pharma
FDA+
Sanders pushes subpoena vote to force testimony of Novo Nordisk exec on GLP-1 prices
Last year
Pharma
FDA+
FDA establishes new meeting type to advise on drug safety technology
Last year
Pharma
FDA+
GSK wins expanded FDA approval for RSV shot in at-risk adults ages 50 to 59
Last year
Pharma
FDA+
FDA greenlights Geron’s imetelstat to treat anemia in certain cancer patients
Last year
Pharma
FDA+
Senate fails to pass bill codifying access to contraception
Last year
Pharma
FDA+
Senate Finance Chair presses HHS to crack down on cybersecurity in wake of UnitedHealth attack
Last year
Pharma
FDA+
House lawmakers float transparency reforms for 340B program at hearing
Last year
Pharma
FDA+
Fauci pushes back on pandemic criticisms before divided House panel
Last year
Pharma
FDA+
Novartis sues Maryland over state law banning limits on discounts to 340B contract pharmacies
Last year
Pharma
Law
Lab group sues FDA over final rule regulating laboratory-developed tests
Last year
Pharma
FDA+
Doctors who endorse drugs on social media are often compensated, JAMA study finds
Last year
Pharma
FDA+
FDA approves Tris Pharma's non-stimulant pediatric ADHD liquid medication
Last year
Pharma
FDA+
Amgen nabs FDA approval for first Soliris interchangeable biosimilar
Last year
Pharma
FDA+
1
2
3
4
Next page
Last page
